ACTA1 and cancer: It is important to note that studies of stromal heterogeneity have identified several different CAF populations, only some of which are α‐SMA‐positive, with each having a different contribution to cancer progression (Costa et al., 2018; Li et al., 2017; Sugimoto et al., 2006).